WTX-124

· Werewolf Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WTX-124, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors [Phase 1]

See pricing